Phanes Therapeutics, Inc.
San Diego California UNITED STATES
Dr. Ming Wang is Founder, President and CEO of Phanes Therapeutics, Inc. based in San Diego, California, USA. The company is focused on drug discovery and early development to treat cancer and metabolic complications. Ming was formerly Vice President and Disease Area Leader of Diabetes/Metabolism in Janssen, the pharmaceutical sector of Johnson & Johnson, with global responsibility for the diabetes portfolio (from discovery stage to phase 2). Previously, Ming was Executive Director and Head of Diabetes Research at Amgen where he headed a group of ~50 scientists located in Amgen’s headquarter (Thousand Oaks) and San Francisco, working on developing novel therapies for metabolic diseases. Ming served on multiple advisory boards, including the Scientific Advisory Board (SAB) of Amgen Ventures. He is a frequent organizer and speaker of biotech and pharma conferences and has 59 publications and a book entitled “Metabolic Syndrome: underlying mechanisms and drug therapies”.
None yet.